USTR ordered to consider actions over foreign nations' pharmaceutical pricing
( May 12, 2025, 18:38 GMT | Official Statement) -- MLex summary: President Donald Trump signed an executive order calling for the US Trade Representative to take potential action against any countries with "unreasonable or discriminatory" policies that force Americans to pay for global pharmaceutical research and development. In the executive order that authorizes steps to lower drug prices, the White House raised concerns about nations "suppressing the price of pharmaceutical products below fair market value in foreign countries."Executive order below:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.